Pipeline and Programs

Evox’s development programs are leveraging the unique inherent abilities of exosomes, namely to modulate the immune system and to target hard-to-reach tissues and organs. Accordingly, Evox’s development pipeline is initially focused on inflammatory and immunologically driven diseases, neuroscience, and on various rare diseases with significant unmet medical need. 

Utilizing its holistic technology platform, Evox is working across therapeutic modalities its lead candidates are based on delivery of both protein therapeutics and nucleic acid-based drugs.

Evox Exesome chart